MODTX — Modus Therapeutics Holding AB Income Statement
0.000.00%
Last trade - 00:00
- SEK65.77m
- SEK50.37m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | SAS | SAS | SAS | SAS | SAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 43.6 | 6.02 | 20.7 | 18 | 16.4 |
Operating Profit | -43.6 | -6.02 | -20.7 | -18 | -16.4 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -43.6 | -6.02 | -20.7 | -18.3 | -17.9 |
Provision for Income Taxes | |||||
Net Income After Taxes | -43.6 | -6.02 | -20.7 | -18.3 | -17.9 |
Net Income Before Extraordinary Items | |||||
Net Income | -43.6 | -6.02 | -20.7 | -18.3 | -17.9 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -43.6 | -6.02 | -20.7 | -18.3 | -17.9 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -2.71 | -0.374 | -1.67 | -1.14 | -1.01 |
Dividends per Share |